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A B S T R A C T
Diﬀerentiating between diﬀerent types of neurodegenerative diseases is not only crucial in clinical practice when
treatment decisions have to be made, but also has a signiﬁcant potential for the enrichment of clinical trials. The
purpose of this study is to develop a classiﬁcation framework for distinguishing the four most common neuro-
degenerative diseases, including Alzheimer's disease, frontotemporal lobe degeneration, Dementia with Lewy
bodies and vascular dementia, as well as patients with subjective memory complaints. Diﬀerent biomarkers
including features from images (volume features, region-wise grading features) and non-imaging features (CSF
measures) were extracted for each subject. In clinical practice, the prevalence of diﬀerent dementia types is
imbalanced, posing challenges for learning an eﬀective classiﬁcation model. Therefore, we propose the use of the
RUSBoost algorithm in order to train classiﬁers and to handle the class imbalance training problem.
Furthermore, a multi-class feature selection method based on sparsity is integrated into the proposed framework
to improve the classiﬁcation performance. It also provides a way for investigating the importance of diﬀerent
features and regions. Using a dataset of 500 subjects, the proposed framework achieved a high accuracy of 75.2%
with a balanced accuracy of 69.3% for the ﬁve-class classiﬁcation using ten-fold cross validation, which is
signiﬁcantly better than the results using support vector machine or random forest, demonstrating the feasibility
of the proposed framework to support clinical decision making.
1. Introduction
Neurodegeneration is a progressive process that results in the gra-
dual loss of nerve structure and function. The neurodegenerative pro-
cess occurs with normal aging, but can be accelerated by many neu-
rodegenerative diseases (NDs), including Alzheimer's disease (AD),
frontotemporal lobe degeneration (FTLD), dementia with Lewy bodies
(DLB), and vascular dementia (VaD). Identifying subjects with a speciﬁc
dementia type is not only crucial in clinical practice, but also beneﬁcial
for developing new treatments and enriching clinical trials. However,
the symptoms of diﬀerent NDs have a high degree of similarity, making
diﬀerential diagnostics diﬃcult. Although there are established clinical
guidelines (Neary et al., 1998; McKhann et al., 1984, 2011; Román
et al., 1993; McKeith et al., 2005) for the diagnosis of diﬀerent NDs,
they are relatively general and require signiﬁcant expertise from clin-
icians in order to reach a correct diagnosis. Therefore, it is essential to
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develop computer-aided decision support systems that can increase the
conﬁdence and accuracy of diﬀerential diagnostics of NDs in clinical
practice.
Neuroimaging techniques have been widely used to detect patho-
logical changes associated with NDs. For example, magnetic resonance
(MR) T1-weighted imaging has been successfully used in the detection
of atrophy patterns in subjects with AD (Cuingnet et al., 2011; Tong
et al., 2014; Thung et al., 2014), FTLD (Du et al., 2007), DLB (Whitwell
et al., 2007) and VaD (Zarow et al., 2005). The atrophy patterns in-
cluding the aﬀected regions and the atrophy rates associated with dif-
ferent types of dementia are diﬀerent, thus providing discriminative
information for the diﬀerential diagnostics of these NDs. Features such
as subcortical volumes and cortical thickness which reﬂect the atrophy
patterns can be used as biomarkers for diﬀerential diagnostics. In ad-
dition, white matter changes (i.e. hyperintensity) are typical for pa-
tients with VaD and can be well detected using Fluid Attenuated In-
version Recovery (FLAIR) imaging. This provides additional
information for distinguishing VaD from the other dementia types.
Among diﬀerent NDs, AD is the most common cause of dementia,
accounting for 60%–70% of all dementia cases (Frisoni et al., 2010),
while every other ND accounting for less than 20% (McKeith et al.,
2004; Van Straaten et al., 2004; Du et al., 2007). This imbalance in the
prevalence of diﬀerent dementias poses challenges for learning an ef-
fective classiﬁcation model as most commonly used classiﬁcation al-
gorithms tend to favour classifying subjects to the majority class (i.e.
AD) compared to the minority classes (i.e. VaD and DLB). For example,
in our dataset, the number of AD subjects is about ten times that of VaD
subjects and about ﬁve times that of DLB subjects. Therefore, machine
learning techniques that can handle the problem of class imbalance are
required in order to learn an eﬀective model for the diﬀerential diag-
nostics. There are two major categories of approaches to handle class
imbalance. One category of approaches is based on cost-sensitive
learning (Zhang and Zhou, 2010; Thai-Nghe et al., 2010). In these
methods, a high cost is assigned to the misclassiﬁcation of minority
classes while simultaneously minimizing the overall cost. The other
major category uses a sampling technique (Chawla et al., 2002; Seiﬀert
et al., 2010) to create a balanced dataset for training. In our work, we
used the second one to alleviate the eﬀect of an imbalanced dataset on
the classiﬁer training. Speciﬁcally, the RUSBoost algorithm proposed in
Seiﬀert et al. (2010) was adopted since it is simpler, faster and can
achieve better performance (Seiﬀert et al., 2010) compared to other
approaches such as AdaBoost (Rätsch et al., 2001) and SMOTEBoost
(Chawla et al., 2003).
In addition to obtaining accurate diﬀerential diagnostics, it is also
interesting to know which biomarkers are most important in the diag-
nostics. Multiple biomarkers can be extracted from MR T1-weighted or
FLAIR images for analysis. However, not all of them contribute equally
to the diagnostic accuracy. Feature selection is an essential step that
selects informative biomarkers while eliminating irrelevant biomarkers
in order to train eﬀective classiﬁers. In addition, feature selection may
provide interpretable results for understanding the underlying pathol-
ogies behind diﬀerent diseases. Most feature selection methods such as
t-tests or Elastic Net sparse regression (Moradi et al., 2015) can select
discriminative features that show signiﬁcant diﬀerences between two
groups of patients. They are therefore tuned towards a binary classiﬁ-
cation scenario. However, these approaches do not guarantee that the
selected features in binary classiﬁcation would be useful in multi-class
classiﬁcation. A multi-class feature selection method is required in our
diﬀerential diagnostic task to identify the useful biomarkers.
In this work, our objective is to develop an eﬀective classiﬁcation
framework for accurate diﬀerential diagnostics of diﬀerent NDs.
Previous studies (Varma et al., 2002; Grossman et al., 2004; Davatzikos
et al., 2008; Burton et al., 2009; Muñoz-Ruiz et al., 2012; Raamana
et al., 2014) have been carried out for the diﬀerential diagnostics of
dementias in diﬀerent classiﬁcation scenarios. However, most previous
studies were based on binary classiﬁcations. The multi-class
classiﬁcation may be more useful to clinicians than the binary classi-
ﬁcation as it represents a real-world clinical scenario. In a recent study
(Koikkalainen et al., 2016), we have presented a multi-class classiﬁca-
tion framework on the diﬀerential diagnostics of dementias. In com-
parison with our previous study in Koikkalainen et al. (2016), the major
contributions of this work include (1) the extraction of more sophisti-
cated region-wise grading features than those in Koikkalainen et al.
(2016). Speciﬁcally, in this study, two types of grading features were
extracted for analysis. The atrophy grading features extracted from T1-
weighted images can capture the atrophy information for classiﬁcation
while the VaD grading features utilize vascular changes from the FLAIR
images; (2) the introduction of the RUSBoost algorithm to handle the
class imbalance problem; and (3) the integration of a multi-class feature
selection step to select useful biomarkers for classiﬁcation and to show
the importance of diﬀerent biomarkers and regions. Cross-sectional
studies are performed on a large dataset of 500 subjects including 118
patients with subjective memory complaints (SMC), 219 AD patients,
92 FTLD patients, 47 DLB patients and 24 VaD patients. In the re-
mainder of the paper, we will ﬁrst introduce the dataset used in our
work in Section 2.1. The calculation of diﬀerent biomarkers is in-
troduced in Section 2.3 and the classiﬁcation framework using feature
selection and RUSBoost is then presented in Sections 2.4 and 2.5 re-
spectively. The performance of the proposed framework is analyzed in
Section 3. Finally, we discuss the strengths and weaknesses of our work
in Section 4 and conclude this paper in Section 5.
2. Material and methods
2.1. Dataset
Data used in the preparation of this article were obtained from the
Amsterdam Dementia Cohort (van der Flier et al., 2014). A group of
500 patients who visited the Alzheimer Center between 2004 and 2014
were studied in this work. All patients received a standardized and
multi-disciplinary work-up, including medical history, physical, neu-
rological and neuropsychological examination, MRI, laboratory test and
lumbar puncture to collect cerebrospinal ﬂuid. A MR T1-weighted
gradient echo sequence was performed for each patient to capture the
atrophy patterns of diﬀerent NDs. 97 and 317 patients were imaged
using 1.5 T and 3.0 T devices respectively. The remaining 86 patients
were imaged using 1.0 T device. The voxel sizes of T1-weighted images
varied between 0.9×0.9×0.9 mm3 and 1.1×1.1×1.5 mm3. In ad-
dition, a fast FLAIR sequence was also carried out for each patient. The
voxel sizes of the obtained FLAIR images varied between
0.4×0.4×1.0 mm3 and 1.2×1.2×6.5 mm3.
The diagnosis of patients were made in a multidisciplinary con-
sensus meeting according to several criteria: probable AD was assigned
according to the criteria of National Institute on Aging-Alzheimer's
Association (McKhann et al., 2011) and the criteria of National Institute
for Neurological and Communicative Diseases Alzheimer's Disease and
Related Disorders Association (McKhann et al., 1984); FTLD was as-
signed based on the Neary criteria (Neary et al., 1998) and the revised
criteria from Rascovsky et al. (2011); DLB was diagnosed using the
McKeith criteria (McKeith et al., 2005); Patients were diagnosed with
VaD using the criteria of National Institute of Neurological Disorders
and Stroke and Association Internationale pour la Recherche et l’En-
seignement en Neurosciences (Román et al., 1993); patients with SMC
were diagnosed only when the cognitive complaints and tests could not
meet the criteria for mild cognitive impairment (MCI), dementia or
other neurological or psychiatric disorder. In addition, follow up of
patients with SMC took place by annual routine visits with a mean of
2.5± 1.4 years and a minimal of 9 months. Only SMC patients who
were conﬁrmed to remain stable during the follow-up were included in
this study. Cognitive functions were assessed with a standardized test
battery consisting of the Mini Mental State Examination (MMSE), the
Cambridge Examination for Mental Disorders of the Elderly (CAMCOG)
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forward and backward conditions of Digit Span, the Visual Association
Test (VAT), the Rey Auditory Verbal Learning Test (RAVLT), the Ca-
tegory Fluency Test (CFT) (animals), the Trail Making Test (TMT), the
Frontal Assessment Battery (FAB), the Stroop test and the Rey ﬁgure
copy test. Depressive symptoms were assessed by the Geriatric De-
pression Scale (GDS), behavioural and psychological symptoms by the
Neuropsychiatric Inventory (NPI) and activities of daily living using the
Disability Assessment for Dementia (DAD). These neuropsychological
tests were used in the above criteria for diagnosis. The study was ap-
proved by the local Medical Ethical Committee. All patients have signed
written informed consent for their clinical data to be used for research
purposes. The demographic information of the dataset is shown in
Table 1.
2.2. Image preprocessing
All T1-weighted images were bias corrected using the N4 bias ﬁeld
correction algorithm (Tustison et al., 2010) and skull-stripped using the
pincram method (Heckemann et al., 2015). After that, non-rigid regis-
tration based on B-spline free-form deformation (Rueckert et al., 1999)
with a ﬁnal control point spacing of 10 mm was performed to align all
T1-weighted images to the MNI152 template space. The approach
proposed in Nyúl and Udupa (1999) was used to normalize the image
intensities between the subjects and the template. Each FLAIR image
was aligned to the T1-weighted image of the same subject using aﬃne
registration, followed by a non-rigid transformation to the template
space. The intensity normalization approach (Nyúl and Udupa, 1999)
was also applied to all the FLAIR images. After preprocessing, all the
images were in the same template space and the intensities of images
from the same modality were at a comparable scale. In addition, it was
noted that the images acquired with the 1.0 T MRI device produced
systematic diﬀerences as compared to images acquired with the 1.5 T
and 3 T MRI. Consequently, a regression step was added to remove this
systematic error from the intensities, making it possible to simulta-
neously compare images acquired with diﬀerent MRI devices.
2.3. Extraction of features
For each patient, a total of 824 features was extracted as biomarkers
for analysis as shown in Table 2, including 138 volume features, 682
grading features, 3 CSF measures and age. How these features were
extracted is described in the following:
Volume features: T1-weighted images were segmented into 138
anatomical regions using multi-atlas label propagation with ex-
pectation-maximization (MALPEM) (Ledig et al., 2015). 30 T1-
weighted images which were manually segmented by Neuromor-
phometrics, Inc. (http://Neuromorphometrics.com) were used as
atlases. First, all 30 atlases were transformed to a target image space
using non-rigid registration (Rueckert et al., 1999). Then, atlas label
maps were transformed using the obtained transformations. Finally,
a label fusion step with an expectation-maximization (EM) reﬁne-
ment (Ledig et al., 2015) was conducted to obtain a consensus
segmentation. The output of the segmentation includes 138 brain
structures whose volumes were used as features. These volume
features can capture the atrophy patterns of diﬀerent NDs, providing
discriminative information for classiﬁcation. The cerebral white
matter region was further segmented into 130 subregions using an
extension of the method (Ledig et al., 2015), where a white matter
atlas is aﬃnely aligned to provide a ﬁner white matter parcellation.
Here, we employed the white matter atlas presented in Oishi et al.
(2009). The white matter subregions were used for calculating the
VaD grading features as described in the following paragraph. Fig. 1
shows an example of the segmentation results.
Grading features: Although volume-based imaging biomarkers pro-
vide good characterization of brain atrophy patterns, their cap-
ability is limited by the inter-subject variability of brain anatomy
(Coupé et al., 2012). The grading features (Coupé et al., 2012),
which calculate scoring values for each test subject by estimating its
similarity to diﬀerent training populations, have been shown to
allow for a better characterization of structural atrophy for the de-
tection of AD (Coupé et al., 2012) than the volume features. In this
work, we propose to calculate region-wise grading features using
sparse regression techniques. Speciﬁcally, a grading value was cal-
culated within each brain structure. Given the intensities of a test
subject Itest ∈ Rk×1 and the intensities of n training subjects Itraining ∈
Rk×n within a structure i, the structure-speciﬁc grading score gi of
this test subject can be calculated by minimizing the following cost
function (Tong et al., 2017):
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Here ̂αi are the coding coeﬃcients of the test subject for structure i
and yj is the disease label vector for the jth training subject. Each
training label vector is deﬁned as yj=[0,…1…,0], where the non-
zero entry position indicates the disease label of a speciﬁc group.
Most of the coeﬃcients in ̂α are zero due to the L1 regularization
over α. By adding the L2 norm in Eq. (1), a grouping eﬀect can be
obtained over the sparse coding coeﬃcients. Qualitatively speaking,
an algorithm exhibits the grouping eﬀect if the coding coeﬃcients of
a group of highly correlated subjects tend to be equal. For example,
there are two training subjects with very similar or identical in-
tensity patterns. If we just use the L1 norm, it will select one of them
while eliminating the other one. However, in calculating the grading
biomarkers, both subjects are similar to the target subject within
structure i and should be used to propagate their disease information
to the target subject. After adding the L2 norm as in Eq. (1), both
subjects can be selected in calculating the grading biomarkers. If the
jth coeﬃcient in ̂αi is not zero, it indicates that the corresponding jth
training subject has been selected to propagate its clinical label in-
formation to the test subject.In our work, two types of grading
Table 1
Demographic information of the dataset used in this study. MMSE: Mini-Mental State
Examination; AD: Alzheimer's disease; FTLD: frontotemporal lobe degeneration; DLB:
dementia with Lewy bodies; VaD: vascular dementia; SMC: subjective memory complaints
as a control group.
Group Number Age MMSE Diagnosis criteria
AD 219 65.9± 7.3 20.6± 4.5 McKhann et al. (1984) and
McKhann et al. (2011)
FTLD 92 63.2± 6.7 23.7± 5.2 Neary et al. (1998) and Rascovsky
et al. (2011)
DLB 47 68.5± 5.7 23.8± 4.7 McKeith et al. (2005)
VaD 24 68.1± 8.6 23.1± 3.7 Román et al. (1993)
SMC 118 60.4± 8.5 28.4± 1.3 Did not meet the criteria for MCI,
dementia or other neurological or
psychiatric disorder
Table 2
A summary of the features used in our study.
Features Modality Dimension
Volume T1-weighted 138
SMC grading T1-weighted 138
AD grading T1-weighted 138
DLB grading T1-weighted 138
FTLD grading T1-weighted 138
VaD grading FLAIR 130
CSF CSF 3
Age – 1
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features were extracted separately: atrophy grading and VaD
grading. The atrophy grading features were calculated using T1-
weighted images only. They include SMC grading, AD grading, FTLD
grading and DLB grading. These grading features were calculated
within each of the 138 structures in the brain region, generating
552(4×138) atrophy grading features in total. In order to char-
acterize the white matter changes that are typical to VaD, VaD
grading features were calculated separately using FLAIR images.
This was carried out in order to diﬀerentiate VaD patients from
other patients. A VaD grading value was computed within each of
the 130 white matter subregions. This provides us with additional
130 grading features. Fig. 2 shows the mean grading maps of pa-
tients in diﬀerent groups.
CSF features: In addition to the features extracted from MR images,
we also utilized the CSF biomarkers including Aβ42, total-tau (t-
tau), and phosphorylated-tau (p-tau) in our study. These biomarkers
have been shown to be highly related to Alzheimer's neuro-
pathology, and can provide useful information in diﬀerentiating AD
from other types of dementia (Schoonenboom et al., 2012).
2.4. Multi-class feature selection
For each patient, 824 features were extracted as described in the
previous section. Some of these features may not be relevant to some of
the pathological changes occurring in NDs and therefore do not provide
useful information for the multi-class classiﬁcation task. In order to
train more eﬀective classiﬁers, these features should be eliminated.
However, it does not necessarily mean that a feature which captures the
pathological changes of NDs is always useful for multi-class classiﬁca-
tion. In an extreme case, for example, if a feature is equally aﬀected by
diﬀerent NDs (i.e. same atrophy pattern in a speciﬁc region), this fea-
ture will not provide discriminative information for diﬀerential diag-
nostics even though it reﬂects the pathological changes of NDs.
Therefore, it is essential to apply a multi-class feature selection ap-
proach to select those discriminative features which show diﬀerences
among all classes.
Most existing feature selection approaches (Saeys et al., 2007) such
as t-test or sparse regression techniques (Moradi et al., 2015) aim to
select discriminative features between two groups of patients. However,
the selected features in binary classiﬁcation are not guaranteed to be
useful in multi-class classiﬁcation. Argyriou et al. (2008) proposed a
Fig. 1. An example of the calculated segmentations of an T1-weighted MR image. The top row presents the original image and the yellow contour illustrates the result of skull stripping.
The second row shows the segmentation of 138 regions and the bottom row adds the further segmentation of the white matter region into 130 subregions. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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multi-class feature selection method by assuming that a small subset of
features are shared by diﬀerent classes and formulated the problem as
the l2,1-norm regularized non-smooth optimization problem:
= − +Ŵ X W Y β Warg min
W
T
F
2
2,1 (2)
Here ∥.∥F denotes the Frobenius norm of a matrix. X ∈ Rd×N are the
features with a dimensionality of d and Y ∈ RN×c are the corresponding
label vectors with c classes. W is the selection matrix. The l2,1-norm
regularization on W penalizes each row of W as a whole and enforces
sparsity among the rows, which allows the selection of informative
features shared by multiple groups for classiﬁcation. Eq. (2) can be
eﬃciently solved using the ﬁrst-order black-box method (Liu et al.,
2009). The l2,1-norm regularization is based on a strict assumption that
all groups share a common set of discriminative features. However, in
many cases, the common set is shared by many groups, but not all. In
order to alleviate this strong assumption, we add a l1-norm regularizer
as proposed in Wang et al. (2011) to impose the sparsity among all
elements in W:
= − + +Ŵ X W Y β W β Warg min
W
T
F
2
1
1
2
2,1 (3)
After the above equation is solved using an iterative algorithm
(Wang et al., 2011), the selected features are determined according to
non-zero coeﬃcients inŴ .
2.5. Multi-class classiﬁcation using RUSBoost
As shown in Table 1, our dataset is imbalanced (the numbers of VaD
and DLB subjects are much smaller than the other three groups), which
poses challenges for traditional classiﬁers such as support vector ma-
chine (SVM) to learn eﬀective classiﬁcation models. The RUSBoost al-
gorithm (Seiﬀert et al., 2010) combines the random under-sampling
(RUS) technique with the AdaBoost algorithm (Rätsch et al., 2001) to
tackle the imbalanced training problem and to learn strong classiﬁers.
In this method, an ensemble of classiﬁers are trained using a randomly
under-sampled subset of the available data. In each iteration of RUS-
boost, the weight of each sample is adjusted. The weights of mis-
classiﬁed samples are increased while the weights of correctly classiﬁed
samples are decreased. Therefore, the misclassiﬁed samples are more
likely to be correctly classiﬁed in subsequent iterations. The ﬁnal
classiﬁcation is a weighted combination of the results of all classiﬁers in
the ensemble. Since minority class samples are most likely to be mis-
classiﬁed at the ﬁrst iteration, they will receive higher weights during
the subsequent iterations and be correctly classiﬁed in the boosting
process.
Assume we are given a set of n training samples S, including {X,Y}
={(x1,y1),(x2,y2),⋯ ,(xn,yn)}. X are the input features and Y are cor-
responding labels. Each training sample in S is assigned an initial
weight = = …D i i n( ) , 1, 2, ,n1 1 . For each iteration = …t T1, 2, , , the
RUSBoost algorithm performs the following steps:
1. Create a subset of training samples St with distribution Dt using
random under-sampling
2. Learn a weak classiﬁer ht : St →Yt using decision trees, given an
input of St
3. Do predictions on all training samples S using ht
4. Calculate the pseudo-loss for S:
= ∑ − +≠ D i h x y h x yϵ ( )(1 ( , ) ( , ))t i y y y t t i i t i( , ): i
5. Calculate the weight for the weak classiﬁer ht:
= −αt ϵ1 ϵt t
6. Update the weight Dt(i) for each sample:
=+ + − ≠D i D i α( ) ( )t t t h x y h x y y y1 (1 ( , ) ( , : ))t i i t i i
1
2
7. Normalize the weights Dt+1:
=+ ∑ += +D i( )t
D i
D i1
( )
( )
t
i
n t
1
1 1
Fig. 2. The average grading maps for each patient group.
For each subject, 682 grading features were extracted, in-
cluding 138 SMC grading features (the ﬁrst column), 138
AD grading features (the second column), 138 FTLD
grading features (the third column), 138 DLB grading fea-
tures (the fourth column) and 130 VaD grading features
(the ﬁfth column). The VaD grading features were extracted
in the white matter subregions using FLAIR images. The
other grading features were extracted in the grey matter
subregions using T1-weighted images.
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After T iterations of the above steps, T weak classiﬁers ht with
weights αt are obtained. The ﬁnal output can be calculated as
∑=
∈ =
H x h x y
α
( ) argmax ( , )log 1
y Y t
T
t
t1 (4)
2.6. Implementation details
For training classiﬁers, SVM, random forest (RF), multi-class cost
learning kNN (mckNN), the synthetic minority over-sampling technique
(SMOTE) and RUSBoost were used. The implementation of SVM was
performed using libsvm in Matlab (https://www.csie.ntu.edu.tw/
~cjlin/libsvm/). The random forest classiﬁer was implemented via
(http://code.google.com/p/randomforest-matlab). The number of trees
in random forest was set to 500 and the number of features randomly
selected at each tree node was set to the square root of the total number
of features as suggested in Liaw and Wiener (2002). mckNN is a cost
learning method proposed in Zhang and Zhou (2010) to handle the
class imbalance problem. The implementation of mckNN from (http://
lamda.nju.edu.cn/code_mcKLR.ashx) was utilized. SMOTE proposed in
Chawla et al. (2002) is an over-sampling technique to handle the im-
balance problem, and the implementation from (http://lamda.nju.edu.
cn/code_CSNN.ashx) was used. To perform RUSBoost, the number of
iterations T was set to 500 in all experiments. All features were nor-
malized to have zero mean and unit variance before the classiﬁcation.
To evaluate the classiﬁcation performance, 10-fold cross validation was
carried out. The reported results in terms of overall accuracy and ba-
lanced accuracy are averages over 100 runs, which are calculated as
=Overall Accuracy number of all correctly classified subjects
total number of all subjects (5)
= ∑=
Balanced Accuracy
c i
c i
i
1
1
number of correctly classified subjects in group
number of subjects in group (6)
To assess the statistical signiﬁcance of diﬀerent results, the Mann
Whitney U Test were performed using the accuracies of 100 runs. In
addition, the area under this curve (AUC) was used as another perfor-
mance measure. In contrary to accuracy, AUC measurement does not
require a threshold on the classiﬁer's output probabilities and thus does
not rely on the class priors. The multi-class AUC (MAUC) was calculated
based on the method proposed in Hand and Till (2001).
3. Results
3.1. The advantage of RUSBoost
Using all the 824 features, we validated the classiﬁcation perfor-
mance of diﬀerent classiﬁers: SVM, RF, mckNN and RUSBoost. Fig. 3
compares the classiﬁcation results using diﬀerent classiﬁers. In addi-
tion, the confusion matrices of the classiﬁcation results are shown in
Fig. 4 for comparison. As can be seen from Fig. 3, the overall accuracies
of RF and RUSBoost are signiﬁcantly better than that using SVM. Al-
though RF achieves the best overall accuracy, the balanced accuracy of
RF is the worst. The imbalanced training set causes RF to be biased
towards the majority groups. This bias can be conﬁrmed by the con-
fusion matrix of RF in Fig. 4. RF achieved very high sensitivities in the
classiﬁcation of AD and SMC, while the sensitivities in detecting VaD
and DLB are nearly zero. Interestingly, SVM is biased to minority
groups as shown in Fig. 4. The highest sensitivity using SVM was ob-
served for the VaD group. In SVM, Support Vectors (SVs) are selected
from each group. Only SVs are used for building classiﬁcation models
while many samples of majority groups far from the decision boundary
are not used. The percentage of SVs in minority groups (i.e. VaD group)
is much higher than that in majority groups (i.e. AD group), which may
result in the bias of SVM towards minority groups. In comparison with
SVM and RF, the results using mckNN and RUSBoost are less biased
since they were proposed to handle the class imbalance problem. The
sensitivities of each group using mckNN and RUSBoost are sensible as
shown in their confusion matrices. Overall, RUSBoost achieved a good
overall accuracy with much higher balanced accuracy than the other
three approaches.
3.2. Comparison of results using diﬀerent features
In a further experiment, we investigated and compared the classi-
ﬁcation performance when diﬀerent types of features were used.
RUSBoost was used for classiﬁer training and testing. Fig. 5 shows the
classiﬁcation results using diﬀerent feature types. The classiﬁcation
results using grading features are more accurate than those using vo-
lume features. Both the grading features and volume features were
extracted from MR images. However, the volume features were calcu-
lated based on the T1-weighted images only, which capture the atrophy
pattern of diﬀerent NDs for classiﬁcation. The grading features were
extracted using information from both the T1-weighted and FLAIR
images, which not only capture the atrophy pattern from T1-weighted
images but also the white matter changes from FLAIR images. This
provides additional information for classiﬁcation, resulting in a more
accurate classiﬁcation performance as compared to volume features.
Moreover, the combination of all features resulted in the best classiﬁ-
cation performance, indicating complementary information between
the MR features and the CSF biomarkers.
3.3. Beneﬁt of feature selection
In the above classiﬁcation experiments, all the 824 features were
used for classiﬁcation. However, some features may not be informative
for the ﬁve-class classiﬁcation. Thus, we applied the multi-class feature
selection step as described in Section 2.4. The results after feature se-
lection are compared to those without feature selection. As shown in
Table 3, the performance of RUSBoost can be signiﬁcantly improved
after feature selection (the p-value is less than 0.001). The feature se-
lection can improve both the overall and balanced accuracies of all
classiﬁers except for the balanced accuracy of SVM. The overall accu-
racy of SVM was increased after feature selection since SVM is biased to
minority groups as demonstrated in Section 3.1, while this may hamper
the improvement of the balanced accuracy. Overall, RUSBoost achieved
signiﬁcantly higher balanced accuracy than the other classiﬁers. The
average confusion matrix of 100 cross validations using RUSBoost after
feature selection is presented in Fig. 6. As shown in Fig. 6, the VaD
patients were mostly misclassiﬁed as AD patients. The most challenging
group are the DLB patients, which were frequently misclassiﬁed as SMC
and AD patients. In addition, we carried out the classiﬁcation by just
using imaging biomarkers including the volume and grading features. A
classiﬁcation accuracy of 70.0% with a balance accuracy of 67.2% was
achieved.
3.4. Most discriminative features and regions
In addition to obtaining accurate diﬀerential diagnostics, it is also
interesting to investigate which features and structures are most im-
portant and informative for the diagnostics. In order to estimate the
importance of diﬀerent features, feature selection was repeatedly car-
ried out on subsets of the data in the 100 runs of ten-fold cross vali-
dation. The selection frequency, which was normalized into [0,1],
provides a measure of importance for each feature and was used in our
work. If the selection frequency of a feature is 1, it means that this
feature is consistently selected across all runs. Features which are
consistently selected can be considered as more important than those
which are only selected occasionally. We ranked the importance of
diﬀerent features according to their selection frequencies in the feature
selection step. The ranked list of the feature importance can be found at
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http://scholar.harvard.edu/ﬁles/ttong/ﬁles/featureimportance.txt.
The top 30 features consist of 3 volume features, 23 grading features,
age and 3 CSF biomarkers. In addition, we mapped the importance of
the grading features and the volume features into the MNI152 template
space for visualization as shown in Fig. 7.
In order to estimate the importance of each structure, the selection
frequencies of diﬀerent features within each structure were added up,
including the selection frequencies of the volume features and the ﬁve
grading features. The summed frequency was treated as the importance
of each structure. We ranked the summed frequencies of all structures.
Fig. 3. Comparison of classiﬁcation performance using diﬀerent classiﬁers. Results were obtained using 100 runs of 10-fold cross validation. The statistical tests using the Mann Whitney
U Test were performed between the results using RUSBoost and those using other methods. * means that the results are signiﬁcantly diﬀerent from those using RUSBoost with p-
value< 0.001.
Fig. 4. Confusion matrix of the classiﬁcation results using diﬀerent classiﬁers.
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The ranked list is available at http://scholar.harvard.edu/ﬁles/ttong/
ﬁles/regionimportance.txt. The most selected structures include the
hippocampus, the entorhinal cortex, amygdala, the middle occipital
gyrus and the accumbens area, implying that these structures are
important indicators for the diﬀerential diagnostics of NDs. In addition,
the highly selected structures have been shown to be more dis-
criminative in the left brain than those in the right brain. Take the
hippocampus as an example, the right hippocampus volumes of the
FTLD patients have similar average size as those of AD and VaD as
shown in Fig. 8. However, the left hippocampus of the FTLD patients
has smaller average size than those of all the other groups. This in-
dicates that the FTLD patients have similar atrophy in the right hip-
pocampus as the AD and VaD patients, but have larger atrophy in the
left hippocampus than other groups. Therefore, the left hippocampus
can provide useful information for distinguishing the FTLD patients
from the other groups. This is why both the grading feature and the
volume feature of the left hippocampus were consistently selected for
classiﬁcation as shown in the ranked list of the feature importance. Last
but not least, VaD grading features show highly diﬀerential ability of
VaD from other dementias in the structures of the subcortical precentral
gyrus (PrCG) and the inferior fronto-occipital (IFO) fasciculus of white
matter as shown in Fig. 9. This is consistent with previous ﬁndings
which show white matter hyperintensity in the PrCG (Ngai et al., 2007)
and IFO structures (Sheline et al., 2008), indicating that these struc-
tures are important locations for diﬀerentiating VaD from other de-
mentias.
Fig. 5. Comparison of classiﬁcation performance using diﬀerent types of features. RUSBoost was used for training and testing. Results were obtained using 100 runs of 10-fold cross
validation. The statistical tests using the Mann Whitney U Test were performed between the results using all features and those using each individual type of features. * means that the
results are signiﬁcantly diﬀerent from those using all features with p-value< 0.001.
Table 3
The classiﬁcation results before and after feature selection. FS represents the method after
feature selection. MAUC represents multi-class area under the curve. The statistical tests
using the Mann Whitney U Test were performed between the overall accuracies using
methods without feature selection and those with feature selection.
Classiﬁer Overall accuracy (%) Balanced accuracy (%) MAUC (%)
SVM 51.9± 1.1 59.5± 1.4 81.8± 0.7
RF 73.8± 0.4 49.6± 0.7 86.2± 0.5
SMOTE 71.0± 0.6 60.1± 1.0 85.0± 1.1
mckNN 69.8± 0.7 57.7± 1.1 –
RUSBoost 72.5± 0.8 66.2± 0.9 88.1± 0.3
SVM_FS* 65.4± 1.4 55.6± 1.9 84.7± 0.9
RF_FS* 75.2± 0.6 52.2± 0.9 87.9± 0.5
SMOTE_FS* 73.1± 1.1 63.8± 1.6 86.7± 1.0
mckNN_FS* 73.4± 1.1 60.0± 1.7 –
RUSBoost_FS* 75.2± 0.8 69.3± 1.0 89.3± 0.5
* Means that the results with feature selection are signiﬁcantly diﬀerent from those
without feature selection with p-value < 0.001. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 6. Confusion matrix of RUSBoost after feature selection using all available features. The values in the right ﬁgure are the corresponding standard variation of the values in the
confusion matrix.
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4. Discussion
In this study, we have developed a novel classiﬁcation framework
for the diﬀerential diagnostics of dementias. First, volume features were
extracted from 138 structures using MR T1-weighted images. In addi-
tion, two types of region-wise grading features were extracted from the
T1-weighted and FLAIR images respectively to capture both the atrophy
information and the vascular changes for classiﬁcation. Finally, three
CSF features and age were added, resulting in a total of 824 features for
each subject. The RUSBoost classiﬁer with a multi-class feature selec-
tion method was then applied to the diﬀerential diagnostics. In the end,
an overall classiﬁcation of 75% with a balanced accuracy of 69% was
obtained using a dataset of 500 subjects. SMC and AD patients can be
well diﬀerentiated with sensitivities over 80%. The sensitivities of dif-
ferentiating FTLD and VaD are over 70%, while the most challenging
group are the DLB patients with a sensitivity of 38%. A large number of
DLB patients were misclassiﬁed as SMC or AD, indicating that there is a
large variation in the DLB group. Some DLB patients are more healthy-
like while some are more atrophy-like.
Previous studies (Varma et al., 2002; Grossman et al., 2004;
Davatzikos et al., 2008; Burton et al., 2009; Muñoz-Ruiz et al., 2012;
Raamana et al., 2014) have reported results for the diﬀerential diag-
nostics of dementias in diﬀerent classiﬁcation scenarios. Since the uti-
lized data are diﬀerent and the classiﬁcation scenarios vary in these
Fig. 7. The importance of diﬀerent features in the MNI152
template space. A high value (in red regions) in the maps
means that the corresponding feature extracted in that re-
gion was selected with a high frequency, indicating that the
feature is important for the ﬁve-class classiﬁcation.
Fig. 8. The distributions of the left and right hippocampus volumes for diﬀerent groups.
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studies, it is diﬃcult to make a direct comparison with these studies. In
comparison with the study in Koikkalainen et al. (2016), more so-
phisticated region-wise grading features were extracted in this study.
These grading features can capture both the atrophy information from
T1-weighted images and the vascular changes from the FLAIR images.
As shown in Table 4, an overall classiﬁcation accuracy of 58.3% was
obtained in Koikkalainen et al. (2016) with a balanced accuracy of
51.5% when the grading features were used. In this work, the classiﬁ-
cation accuracy was improved to 66.6% and the balanced accuracy to
62.7% using the proposed grading features. The improvement resulted
from the calculation of grading features in an anatomical region-wise
way and the introduction of the vascular grading features. In addition,
the RUSBoost algorithm was introduced in this work to handle the class
imbalance problem. The balanced accuracy was 50.7% in Koikkalainen
et al. (2016) when only the volume features were used. This was in-
creased to 58.7% in this work, demonstrating the eﬀectiveness of the
RUSBoost method in handling the class imbalance problem. Moreover,
a multi-class feature selection method was adopted in this work to se-
lect useful features for the ﬁve-class classiﬁcation. The multi-class
feature selection step not only improves the classiﬁcation accuracy but
also allows us to investigate which features and structures are most
important in the classiﬁcation. We have shown that the grey matter
structures including the hippocampus, the entorhinal cortex, amygdala,
the middle occipital gyrus and the accumbens area are important re-
gions for capturing atrophy diﬀerences for diﬀerential diagnostics.
These structures have been reported as important regions for identi-
fying dementias in previous studies (Barber et al., 2000; Schott and Fox,
2007; Frisoni et al., 2010). For example, the early structural changes in
AD have been found to occur in medial temporal lobe, particularly
atrophy of hippocampus and entorhinal cortex (Schott and Fox, 2007;
Frisoni et al., 2010). The atrophy in hippocampus and medial temporal
lobe are relatively preserved in FTLD as compared to AD (Duara et al.,
1999). DLB patients have shown signiﬁcant atrophy as compared to
controls, but relatively preserved in medial temporal lobe, thalamus,
hippocampal, and amygdala volumes as compared to AD (Barber et al.,
2000, 1999). In addition, the PrCG and IFO structures in white matter
have been shown in our study to provide essential information for
diﬀerentiating VaD, which is consistent with previous ﬁndings (Ngai
et al., 2007; Sheline et al., 2008). Moreover, Varma et al. (2002) re-
ported asymmetrical atrophy only in FTLD patients. In our work, we
found asymmetrical hippocampal volumes in the FTLD patients as
shown in Fig. 8, which provides discriminative information for diﬀer-
entiating FTLD from other dementias. These ﬁndings may provide va-
luable insights for clinicians to better understand the characteristics of
diﬀerent NDs.
We have demonstrated that the combination of diﬀerent features
including the grading features, the volume features and the CSF fea-
tures can improve the classiﬁcation accuracy. Age is also an important
predictor in the diﬀerential diagnosis of dementias. It ranked top 30 in
the utilized 824 features, highlighting that age is a risk factor for ND. It
is reported in previous studies (Tong et al., 2017) that older subjects are
more likely to develop AD than younger subjects. Other biomarkers
such as cortical thickness (Hartikainen et al., 2012; Blanc et al., 2015),
voxel-based morphometry (Davatzikos et al., 2008) and deformation-
based morphometry (Muñoz-Ruiz et al., 2012) measures can be com-
bined for classiﬁcation. However, these structural biomarkers have
shared information as our volumetric and grading features, thus may
provide limited complementary information for improving the results.
In contrast with these structural measures, biomarkers from other
modalities such as functional imaging, neuropsychological tests and
genetic data may have more valuable information for improving the
classiﬁcation performance. A further validation was carried out by
combining the proposed features with additional cognitive scores, in-
cluding MMSE, FAB, VAT, RAVLT, TMT, NPI and the Stroop test. The
obtained overall accuracy has been signiﬁcantly improved to 81% with
a balanced accuracy of 78%. These cognitive scores add valuable in-
formation for classiﬁcation. In addition to the combination of multi-
modal biomarkers, developing disease-speciﬁc biomarkers is also es-
sential for improving the classiﬁcation performance. For example, a
VaD-speciﬁc biomarker called vascular burden was developed in
Koikkalainen et al. (2016) to characterize the vascular changes so that
the VaD patients can be separated from other groups. Although it re-
quires the segmentation of lesions to quantify the vascular changes, the
vascular burden biomarker can signiﬁcantly improve the detection
sensitivity of VaD patients to 96% as shown in Koikkalainen et al.
Fig. 9. The distributions of VaD grading features in PrCG and IFO of white matter for diﬀerent groups.
Table 4
Comparison of the results using diﬀerent classiﬁers and features.
Features Method Classiﬁer Overall
accuracy
Balanced
accuracy
Volume
features
Koikkalainen et al.
(2016)
DSI 50.4 50.7
Proposed RUSBoost 58.6 58.7
Grading
features
Koikkalainen et al.
(2016)
DSI 58.3 51.5
Proposed RUSBoost 66.6 62.7
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(2016), which is much higher than 74% obtained in our work, leading
to a similar balanced accuracy as in our work. In addition, the sensi-
tivity for detecting the DLB patients is low since there are no suﬃcient
DLB-speciﬁc changes found in MR T1-weighted and FLAIR images. By
adding neuropsychological tests, the sensitivity for diagnosing the DLB
patients was improved from 38% to 70%. These cognitive scores are
important features for improving the diagnosis accuracy of the DLB
patients. In addition, it would be interesting to develop other DLB-
speciﬁc biomarkers using modalities such as FDG-PET and DaTscan
(McKeith et al., 2007) in future work.
In addition to the extraction of discriminative and complementary
features, the adopted classiﬁer also plays an important factor in the
multi-class classiﬁcation. In this work, we have shown that traditional
classiﬁers including SVM and RF do not work well for the ﬁve-class
classiﬁcation because both classiﬁers are highly aﬀected by the class
imbalance problem. The RUSBoost method has been shown to provide a
good solution to this problem in our work, which utilizes a sampling
technique to handle class imbalance. Other recent approaches (Mac
Aodha and Brostow, 2013; Bahnsen et al., 2015) may provide an al-
ternative way for handling the class imbalance problem. Furthermore,
in this work, diﬀerent types of features were concatenated for classiﬁ-
cation. The feature concatenation provides a straightforward way to
fuse multiple biomarkers, but may not optimally exploit the com-
plementary information among diﬀerent features for classiﬁcation.
How diﬀerent types of biomarkers can be eﬃciently integrated requires
further investigations. Finally, it should be mentioned that a patient
diagnosed with a speciﬁc type of dementia may actually have mixed
dementia. One previous study (Alzheimer's Association et al., 2015)
shows that 54% of 141 volunteers, who had been diagnosed with AD,
showed evidence of another type of dementia such as VaD or DLB ac-
cording to their autopsies. Therefore, it would be interesting to generate
probabilistic maps to visualize the likelihood of a region belonging to
diﬀerent NDs or shared by diﬀerent NDs.
5. Conclusions
In this paper, a feature extraction and classiﬁcation framework was
proposed for the automatic diﬀerential diagnostics of four neurode-
generative diseases including AD, FTLD, VaD, and DLB, as well as pa-
tients with SMC. Structural volumes, structure-speciﬁc grading values
and CSF features were extracted as biomarkers. The experimental re-
sults show that the best performance of the proposed framework was
achieved when all the biomarkers were combined, indicating that there
is complementary information among these biomarkers. In addition,
the class imbalance problem poses challenges to traditional classiﬁers
such as SVM and RF. The introduced RUSBoost algorithm has been
shown to provide a good solution to this problem. In addition, a multi-
class feature selection step has been demonstrated to improve the
classiﬁcation performance of the proposed framework. We also provide
a way to quantify and investigate the importance of diﬀerent features
and regions. The proposed framework achieved a high classiﬁcation
accuracy of 75% for the ﬁve-class diﬀerential diagnostics of 500 pa-
tients, which is notable better than that obtained with visual MRI rat-
ings (44.6%) as presented in Koikkalainen et al. (2016). Although the
proposed framework is required a further improvement on accuracy
before clinical use and further validations on diﬀerent data sets are
needed, it is encouraging to note that there is an increasing trend in the
diagnosis accuracy with the eﬀorts on this challenging task, which will
ﬁnally lead to a prediction rate suitable for clinical use. Cost-eﬃciency
analysis will then be investigated to decide what level of accuracy is
acceptable in clinical practice in future studies.
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